Jazz Pharmaceuticals (JAZZ) Earnings Date, Estimates & Call Transcripts $122.10 +3.02 (+2.54%) (As of 12:52 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Jazz Pharmaceuticals Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 26EstimatedActual EPS (Nov. 6) $5.86 Beat By $1.32 Consensus EPS (Nov. 6) $4.54 Jazz Pharmaceuticals issued Q3 2024 earnings on November 6, 2024, reporting an EPS of $5.86, which topped the consensus estimate of $4.54 by $1.32. Quarterly revenue was reported to be $1.05 billion, above analysts' expectations of $1.04 billion. With a trailing EPS of $7.10 and a P/E Ratio of 20.95, Jazz Pharmaceuticals' earnings are expected to grow 16.35% next year, from $16.02 to $18.64 per share. Conference Call TranscriptConference Call AudioSEC 10-Q/10-K FilingJAZZ Upcoming EarningsJazz Pharmaceuticals' next earnings date is estimated for Wednesday, February 26, 2025, based off prior year's reporting schedules. Get Jazz Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jazz Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataJAZZ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.JAZZ Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsThe secret supplier behind NVIDIA, Tesla and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known supplier, which provides a crucial building block for AI.Click here for the ticker >>> Jazz Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$3.24$3.60$3.42 Q2 20242$3.68$4.23$3.96 Q3 20242$4.34$4.52$4.43 Q4 20241$4.83$4.83$4.83 FY 20247$16.09$17.18$16.64 Q1 20251$3.13$3.13$3.13 Q2 20251$4.09$4.09$4.09 Q3 20251$4.35$4.35$4.35 Q4 20251$4.55$4.55$4.55 FY 20254$16.12$16.12$16.12 Q1 20261$3.77$3.77$3.77 Q2 20261$4.33$4.33$4.33 Q3 20261$4.67$4.67$4.67 Jazz Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/26/2025(Estimated)------- 11/6/2024Q3 2024$4.54$5.86+$1.32$8.30$1.04B$1.05B 7/31/2024Q2 2024$3.80$4.67+$0.87$6.85$1.00B$1.02B5/1/2024Q1 2024$3.53$1.98 -$1.55$4.19$938.99M$901.98M 2/28/2024Q4 2023$4.44$4.40 -$0.04$7.38$1.01B$1.01B 11/8/2023Q3 2023$4.21$4.22+$0.01$6.30$969.47M$972.14M 8/9/2023Q2 2023$3.68$3.83+$0.15$6.14$952.44M$957.32M Get the Latest News and Ratings for JAZZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/10/2023Q1 2023$3.58$3.20 -$0.38$5.36$898.11M$892.81M 3/1/2023Q4 2022--$0.84 -$0.84$2.14$972.70M$972.12M 11/9/2022Q3 2022$4.35$4.53+$0.18$9.37$939.88M$940.65M Jazz Pharmaceuticals Earnings - Frequently Asked Questions When is Jazz Pharmaceuticals's earnings date? Jazz Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates. Learn more on JAZZ's earnings history. What guidance has Jazz Pharmaceuticals issued on next quarter's earnings? Jazz Pharmaceuticals updated its FY 2024 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of 19.500-20.600 for the period, compared to the consensus earnings per share estimate of 19.590. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion. Did Jazz Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported $5.86 earnings per share (EPS) to beat the analysts' consensus estimate of $4.54 by $1.32. Learn more on analysts' earnings estimate vs. JAZZ's actual earnings. How can I listen to Jazz Pharmaceuticals's earnings conference call? The conference call for Jazz Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Jazz Pharmaceuticals's conference call transcript? The conference call transcript for Jazz Pharmaceuticals's latest earnings report can be read online. Read Transcript How can I view Jazz Pharmaceuticals's earnings report? Jazz Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Jazz Pharmaceuticals generate each year? Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded annual revenue of $3.83 billion. How much profit does Jazz Pharmaceuticals generate each year? Jazz Pharmaceuticals (NASDAQ:JAZZ) has a recorded net income of $414.83 million. JAZZ has generated $5.82 earnings per share over the last four quarters. What is Jazz Pharmaceuticals's price-to-earnings ratio? Jazz Pharmaceuticals (NASDAQ:JAZZ) has a trailing price-to-earnings ratio of 20.46 and a forward price-to-earnings ratio of 7.43. The price/earnings-to-growth ratio is 1.37. What is Jazz Pharmaceuticals's EPS forecast for next year? Jazz Pharmaceuticals's earnings are expected to grow from $16.02 per share to $18.64 per share in the next year, which is a 16.35% increase. ` More Earnings Resources from MarketBeat Related Companies RARE Earnings BHC Earnings ACAD Earnings ARWR Earnings RPRX Earnings CORT Earnings PRGO Earnings SUPN Earnings PCRX Earnings OMER Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run The secret supplier behind NVIDIA, Tesla and Microsoft (Ad)The Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known supplier, which provides a crucial building block for AI.Click here for the ticker >>> This page (NASDAQ:JAZZ) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredUrgent: This election is riggedToday, I want to show you how all these warning signs are converging… and how they’re about to reach a breakin...Porter & Company | SponsoredWhat Trump’s victory means for GOLDGold may have suffered a pullback after news of Trump's 2024 election win spread... But don't be mistaken: ...Stansberry Research | SponsoredTrump Won, But Can He Save Your 401(k)?Trump Won, But Your Savings Are Still In Danger It's the ONLY playbook that shows you how to fortify your f...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free jazz Stock Alerts